NPPA fixes retail price of 39 new drugs based on 47 applications: Gireesh Babu, New Delhi Saturday, July 11, 2026, 08:00 Hrs ...
OKYO Pharma announces positive feedback from US FDA Type D Meeting and accelerates urcosimod into global phase 3 trial for NCP: London Saturday, July 11, 2026, 18:00 Hrs [IST] OKY ...
CDA issues reimbursement recommendation for Empaveli to treat C3 glomerulopathy and primary IC-MPGN: Waltham, Massachusetts Saturday, July 11, 2026, 15:00 Hrs [IST] Swedish Orphan ...
Pharma companies are expanding the use of predictive analytics across the value chain: Expert: Shardul Nautiyal, Mumbai Saturday, July 11, 2026, 08:00 Hrs [IST] Pharmaceutical com ...
Dadhichi College in Odisha to organize GRPP training program to elevate community pharmacy standards: Peethaambaran Kunnathoor, Chennai Saturday, July 11, 2026, 08:00 Hrs [IST] Wi ...
Blue Earth Therapeutics and University College London initiate phase 1 trial evaluating Actinium (225Ac) rhPSMA-10.1 injection in mCRPC: Oxford, UK Saturday, July 11, 2026, 16:00 ...
The Indian Pharmaceutical Market is on track to record a highly encouraging double-digit value growth of 11.3 per cent for the full year ending December 2026, according to the latest market data ...
Pharmacy colleges emphasise on multifaceted training as career horizons expand: Nandita Vijayasimha, Bengaluru Saturday, July 11, 2026, 08:00 Hrs [IST] Pharmacy colleges in the co ...
CHOP secures five-year, up to $38.9 million ARPA-H award to advance personalized gene editing therapies: Philadelphia, Pennsylvania Saturday, July 11, 2026, 14:00 Hrs [IST] Childr ...
Cell Therapies supports Australian phase I/Ib clinical trial of A-SEEDS’ ACS2015 CAR-T therapy for solid tumours: Australia Saturday, July 11, 2026, 13:00 Hrs [IST] Cell Therapi ...
WuXi Biologics’ MFG8 drug substance facility secures US FDA Pre-License Inspection approval: Hebei, China Saturday, July 11, 2026, 17:00 Hrs [IST] WuXi Biologics, a leading glob ...
Intas Pharma’s US specialty division, Accord BioPharma receives US FDA approval for Ennumo, a biosimilar to Neulasta: Raleigh, North Carolina Saturday, July 11, 2026, 12:00 Hrs ...